Amanote Research
Register
Sign In
Targeted Degradation of KRAS by an Engineered Ubiquitin Ligase Suppresses Pancreatic Cancer Cell Growth in Vitro and in Vivo
Molecular Cancer Therapeutics
- United States
doi 10.1158/1535-7163.mct-12-0650
Full Text
Open PDF
Abstract
Available in
full text
Categories
Cancer Research
Oncology
Date
January 3, 2013
Authors
Y. Ma
Y. Gu
Q. Zhang
Y. Han
S. Yu
Z. Lu
J. Chen
Publisher
American Association for Cancer Research (AACR)
Related search
miR-154 Suppresses Non-Small Cell Lung Cancer Growth in Vitro and in Vivo
Oncology Reports
Medicine
Cancer Research
Oncology
Low Expression of the E3 Ubiquitin Ligase CBL Confers Chemoresistance in Human Pancreatic Cancer and Is Targeted by Epidermal Growth Factor Receptor Inhibition
Clinical Cancer Research
Cancer Research
Oncology
Arkadia, a Novel SUMO-Targeted Ubiquitin Ligase Involved in PML Degradation
Molecular and Cellular Biology
Cell Biology
Molecular Biology
Quercetin-3-O-Glucoside Suppresses Pancreatic Cancer Cell Migration Induced by Tumor-Deteriorated Growth Factors in Vitro
Oncology Reports
Medicine
Cancer Research
Oncology
Knockdown of TRAF4 Expression Suppresses Osteosarcoma Cell Growth in Vitro and in Vivo
International Journal of Molecular Medicine
Medicine
Genetics
E3 Ubiquitin Ligase RNF126 Promotes Cancer Cell Proliferation by Targeting the Tumor Suppressor P21 for Ubiquitin-Mediated Degradation
Cancer Research
Cancer Research
Oncology
Adrenomedullin Antagonist Suppresses in Vivo Growth of Human Pancreatic Cancer Cells in SCID Mice by Suppressing Angiogenesis
Oncogene
Cancer Research
Genetics
Molecular Biology
SPOP Suppresses Pancreatic Cancer Progression by Promoting the Degradation of NANOG
Cell Death and Disease
Molecular Neuroscience
Immunology
Cell Biology
Cancer Research
Cellular
Medicine
MicroRNA-338-3p Suppresses Tumor Growth of Esophageal Squamous Cell Carcinoma in Vitro and in Vivo
Molecular Medicine Reports
Oncology
Genetics
Molecular Biology
Biochemistry
Cancer Research
Molecular Medicine
